应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BK1576 医药外包概念
已收盘 08-11 16:00:00
3,805.242
+15.821
+0.42%
最高
3,937.606
最低
3,785.562
成交量
1.73亿
今开
3,789.421
昨收
3,789.421
日振幅
4.01%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
68.00亿
换手率
--
流通股本
0.00
市净率
4.047797
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
Norges Bank减持康龙化成(03759)280.13万股 每股作价约27.23港元
智通财经 · 19:25
Norges Bank减持康龙化成(03759)280.13万股 每股作价约27.23港元
泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知
证券之星 · 16:33
泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知
港股午评|恒生指数早盘跌0.63% CRO概念继续走高
智通财经 · 12:00
港股午评|恒生指数早盘跌0.63% CRO概念继续走高
港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单
智通财经 · 11:47
港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单
港股异动 | 金斯瑞生物科技(01548)涨近9% 海外Twist已获订单验证 AI需求已开始贡献业务增量
智通财经 · 11:36
港股异动 | 金斯瑞生物科技(01548)涨近9% 海外Twist已获订单验证 AI需求已开始贡献业务增量
创新药概念继续走强 金斯瑞生物科技(01548)涨6.87% 机构指中国创新药全球地位持续提升
金吾财讯 · 11:15
创新药概念继续走强 金斯瑞生物科技(01548)涨6.87% 机构指中国创新药全球地位持续提升
大和:上调药明康德(02359.HK)目标价至230港元 重申行业首选
智通财经 · 10:04
大和:上调药明康德(02359.HK)目标价至230港元 重申行业首选
药明康德(02359)逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
金吾财讯 · 10:00
药明康德(02359)逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
药明康德:公司将于2026年9月29日召开2026年第一次临时股东会
证券日报网 · 08-10 20:34
药明康德:公司将于2026年9月29日召开2026年第一次临时股东会
资金动向|北水加仓MINIMAX超10亿港元,中芯国际遭抛售4.5亿港元
格隆汇 · 08-10 19:05
资金动向|北水加仓MINIMAX超10亿港元,中芯国际遭抛售4.5亿港元
FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元
智通财经 · 08-10 19:02
FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元
大行评级|大摩:药明康德获批出初步禁制令 解除1260H清单不明朗因素
格隆汇 · 08-10 15:28
大行评级|大摩:药明康德获批出初步禁制令 解除1260H清单不明朗因素
中泰国际:维持药明康德(02359.HK)“买入”评级 目标价216港元
智通财经 · 08-10 15:04
中泰国际:维持药明康德(02359.HK)“买入”评级 目标价216港元
大摩:药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素
智通财经 · 08-10 14:47
大摩:药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素
金斯瑞生物科技盘中涨超8% 全球AI制药落地进入兑现期
新浪港股 · 08-10 11:26
金斯瑞生物科技盘中涨超8% 全球AI制药落地进入兑现期
时隔5个月,华宝基金医疗ETF(512170)重新站上年线!药明康德A股突破上轮医药牛市高点,创上市8年新高!
新浪基金 · 08-10 11:17
时隔5个月,华宝基金医疗ETF(512170)重新站上年线!药明康德A股突破上轮医药牛市高点,创上市8年新高!
AH异动丨药明康德H股创新高,A股涨超7%,美法院批准针对1260H认定的初步禁令
格隆汇 · 08-10 10:37
AH异动丨药明康德H股创新高,A股涨超7%,美法院批准针对1260H认定的初步禁令
港股异动 | 金斯瑞生物科技(01548)涨超8% AIDD放大实验验证需求 机构看好“卖水人”逻辑强化
智通财经 · 08-10 10:31
港股异动 | 金斯瑞生物科技(01548)涨超8% AIDD放大实验验证需求 机构看好“卖水人”逻辑强化
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
金吾财讯 · 08-10 09:58
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
港股生物医药股盘初走高,药明康德股价突破200港元关口创历史新高
新浪港股 · 08-10 09:51
港股生物医药股盘初走高,药明康德股价突破200港元关口创历史新高
加载更多
公司概况
公司名称:
BK1576
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":3805.2417,"timestamp":1786435691454,"preClose":3789.4211,"halted":0,"volume":173415814,"delay":0,"changeRate":0.004175,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":15.820557,"latestTime":"08-11 16:00:00","open":3789.4211,"high":3937.6064,"low":3785.562,"amount":6799827562,"amplitude":0.040123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786498200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1786411800000,1786420800000],[1786424400000,1786435200000]],"pbRate":4.047797,"peRate":21.973671,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1576","defaultTab":"news","newsList":[{"id":"2658997383","title":"Norges Bank减持康龙化成(03759)280.13万股 每股作价约27.23港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997383","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658997383?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:25","pubTimestamp":1786447509,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,8月7日,Norges Bank减持康龙化成(03759)280.13万股,每股作价27.2286港元,总金额约为7627.55万港元。减持后最新持股数目约为1609.7万股,最新持股比例为4.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","BK1141","EWH","03759","BK1576","ENOR","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658399311","title":"泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2658399311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658399311?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:33","pubTimestamp":1786437190,"startTime":"0","endTime":"0","summary":"证券之星消息,泰格医药(300347)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问公司被调查的事项,进展到哪一步了?什么时候有个大的方向。泰格医药回复:投资者您好,截至目前,公司实际控制人尚未接到该事项的进一步通知。谢谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100025940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1583","300347","BK0216","BK0174","BK1576","LU1146622755.USD","LU1820825898.SGD","BK0077","BK1141","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969219","title":"港股午评|恒生指数早盘跌0.63% CRO概念继续走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969219?lang=zh_cn&edition=full","pubTime":"2026-08-11 12:00","pubTimestamp":1786420834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌0.63%,跌163点,报25773点;恒生科技指数跌1.27%。港股早盘成交1158亿港元。药明康德司法取得进展,有利于CXO公司在海外争取新的订单。再鼎医药涨超5%,Q2产品收入环比增长11%,花旗看好中国业务下半年企稳。津上机床中国涨超5%,电子与AI液冷两大领域在新订单占比约四成。黄金股普遍承压。油价走高加剧通胀上行担忧,美联储鹰派释放强硬信号。中国黄金国际跌2.5%;紫金矿业跌3.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348827113.USD","03759","LU1794554557.SGD","LU0326950275.SGD","LU0039217434.USD","BK1170","PONY","LU1720050803.USD","LU0370786039.SGD","SG9999003461.SGD","688062","LU1481107354.HKD","03032","LU0269904917.USD","LU2226246903.HKD","LU1188198961.HKD","02493","LU0348766576.USD","LU1770034418.SGD","07200","LU0048580855.USD","BK1583","LU0828237940.HKD","LU0463099449.HKD","LU0164880469.USD","LU0149721374.USD","LU2460026573.USD","002821","07300","ZLAB","BK1198","LU0348825331.USD","LU1988902786.USD","09115","LU0620787316.HKD","06951","01548","LU1303224171.USD","09088","BK1587","LU0327786744.USD","HK0000320223.HKD","LU2097828714.EUR","513600","BK1183","LU0886674414.USD","LU0266512473.USD","LU1224709979.USD","LU0082770016.USD","HK0000306685.HKD","LU0140636845.USD","LU0540923850.HKD","LU1064131342.USD","BK1191","07552","BK1169","LU0061477393.USD","LU1105468828.SGD","LU0509642566.USD","02833","HSTECH","JINFF","03115","IE0032431581.USD","LU0287142896.SGD","LU0737861699.HKD","LU0634319403.HKD","LU0828237510.HKD","LU2177674079.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0181495838.USD","LU0164939612.USD","LU0345780281.USD","LU0228659784.USD","LU0431992006.USD","LU1769817096.USD","03423","82800","HSI","SG9999001093.SGD","LU0868486357.SGD","LU2097828631.EUR","LU3063872942.SGD","LU0456854461.SGD","LU2264538146.SGD","LU0278937759.USD","BK1190","BK1544","06821","02631","BK1576","LU0328353924.USD","LU0082770016.SGD","LU0244354667.USD","LU2097828474.EUR","LU2488822045.USD","LU0797268264.HKD","HK0000306701.USD","LU1242518931.SGD","HK0000320264.USD","LU2399975544.HKD","02837","LU0106252389.USD","HHImain","LU0417516902.SGD","02800","LU0345780521.USD","LU1808992512.USD","03417","LU0173614495.USD","LU0828238088.HKD","300759","BK1588","688234","LU0348767384.USD","LU0164865239.USD","LU1831875114.USD","LU2008162690.USD","01541","BK1574","BK1505","MCHmain","LU1961090484.USD","09688","LU0307460666.USD","BK1592","LU0348735423.USD","ZIJMY","LU0049853897.USD","LU0274383008.USD","BK1129","01651","02026","LU1769817179.HKD","LU0979878070.USD","03088","LU2097828805.USD","601899","LU0572944931.SGD","LU0531971595.HKD","LU0417516738.SGD","BK1141","LU0043850808.USD","LU0821914370.USD","LU1242518857.USD","LU0588546209.SGD","LU1504937902.USD","LU0329678337.USD","LU1251922891.USD","06616","07500","LU2097828557.USD","LU0918141705.HKD","LU0737861772.HKD","83115","02099","LU0348814723.USD","03419","LU0211977185.USD","LU0348816934.USD","LU0469268626.HKD","LU0329678170.USD","09067","02899","LU1282648689.USD","07226","LU1719994722.HKD","BK1161","BK1594","LU0106959298.USD","LU0096374516.USD","LU1048596156.SGD","LU0165289439.USD","03033","LU0871576103.HKD","LU0918141887.USD","LU0561508036.HKD","03037","LU0266512127.USD","SG9999004220.SGD","300408","03067","BK1109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969972","title":"港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969972","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969972?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:47","pubTimestamp":1786420064,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1046422090.SGD","02359","LU0348767384.USD","LU0320764599.SGD","BK1583","BK1141","LU2242644610.SGD","LU2045819591.USD","LU0708995583.HKD","LU0052750758.USD","LU0348766576.USD","BK1576","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969611","title":"港股异动 | 金斯瑞生物科技(01548)涨近9% 海外Twist已获订单验证 AI需求已开始贡献业务增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969611","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969611?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:36","pubTimestamp":1786419380,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,金斯瑞生物科技涨近9%,截至发稿,涨8.94%,报26.32港元,成交额8.27亿港元。中邮证券指,AI制药持续进展,TWST高增验证DBTL闭环,关注产业链成长机遇。国联民生证券认为,金斯瑞从基因合成龙头向“基因至蛋白”一体化验证平台延伸,AI需求已开始贡献业务增量。AI驱动药物开发及多抗体药物开发需求增长,带动基因至蛋白业务快速成长;2025年生命科学事业群收入5.22亿美元,同比增长14.8%,同时持续扩大自动化、数字化生产能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4588","HK0000306685.HKD","HK0000306701.USD","BK1583","BK1141","KCAI","AIPO","HK0000320264.USD","QTOC","CHAT","BK4585","01548","HK0000320223.HKD","VTHR","AGIX","ARTY","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658369969","title":"创新药概念继续走强 金斯瑞生物科技(01548)涨6.87% 机构指中国创新药全球地位持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658369969?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强,截至发稿,金斯瑞生物科技 涨6.87%,再鼎医药涨5.51%,同源康医药-B涨4.81%,晶泰控股涨3.94%,药明合联涨3.92%,翰森制药涨3.76%,亚盛医药涨3.63%,百济神州涨3.38%,药明康德涨3.03%,诺诚健华涨2.83%,石药集团涨2.78%。国元国际证券亦表示,出海交易量价齐升,中国创新药全球地位持续提升。中国创新药出海持续超预期,上半年997亿美元的交易总额和全球TOP10中独占8席的成绩,充分验证了中国创新药资产的全球竞争力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1951186391.HKD","LU0315179316.USD","06978","BK1515","LU0072913022.USD","BK1161","LNGR","IE00B031HY20.USD","HK0000306685.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","BK1617","LU2328871848.SGD","01548","06160","01093","BK1588","03692","159992","HK0000320223.HKD","IE00B543WZ88.USD","LU2125910500.SGD","02359","06855","KURE","LU2039709279.SGD","LU1152091168.USD","BK1576","BK1521","09969","09688","IE00BZ08YS42.EUR","LU1226288170.HKD","IBBQ","LU0326950275.SGD","LU1226287792.SGD","LU1303224171.USD","LU1993786604.SGD","LU2242644610.SGD","MEDX","LU1813983027.USD","02228","IE00BZ08YR35.GBP","BK1583","02410","02268","IE00BZ08YT58.USD","LU2488822045.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658896570","title":"大和:上调药明康德(02359.HK)目标价至230港元 重申行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2658896570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658896570?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:04","pubTimestamp":1786413860,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","02359","LU2242644610.SGD","LU0708995583.HKD","LU0348767384.USD","LU2125910500.SGD","LU0052750758.USD","LU1046422090.SGD","LU0320764599.SGD","LU0348766576.USD","BK1141","BK1576","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657219","title":"药明康德(02359)逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657219","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658657219?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:00","pubTimestamp":1786413650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德(02359)早盘逆市走高,截至发稿,报202港元,涨2.02%,成交额3.7亿港元。大和研报指,美国哥伦比亚特区联邦地区法院颁发初步禁制令,禁止美国国防部将药明康德列入1260H名单,使公司在诉讼期间免受被错误列入1260H名单所带来的不利后果,将目标市盈率由20倍上调至21.5倍,目标价由215港元升至230港元。该行相信,这项初步禁制令是药明康德从1260H名单除名程序及时的第一步,亦代表公司在法律程序中取得初步胜利,维持“买入”评级。重申行业首选。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987890","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0611395673.USD","LU0700851271.USD","LU1934453819.USD","LU1997245094.SGD","LU0320764599.SGD","IE00B543WZ88.USD","LU2495084118.USD","LU1997245177.USD","LU2488822045.USD","LU1303224171.USD","LU1969619763.USD","LU2242644610.SGD","LU1770034418.SGD","LU2328871848.SGD","LU1997244956.HKD","LU0348766576.USD","BK1583","LU1719994722.HKD","LU1979443071.USD","LU1046422090.SGD","BK0216","LU0348767384.USD","LU2045819591.USD","LU1808992512.USD","603259","LU0052750758.USD","LU2125910500.SGD","BK1576","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","02359","LU0456842615.SGD","LU1251922891.USD","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939798","title":"药明康德:公司将于2026年9月29日召开2026年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939798","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939798?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:34","pubTimestamp":1786365240,"startTime":"0","endTime":"0","summary":"证券日报网讯 8月10日,药明康德发布公告称,公司将于2026年9月29日召开2026年第一次临时股东会。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320764599.SGD","LU0700851271.USD","LU0348767384.USD","IE00B5MMRT66.SGD","BK0216","LU2125910500.SGD","LU2328871848.SGD","603259","IE00B543WZ88.USD","LU2242644610.SGD","BK1576","LU1303224171.USD","02359","LU0611395673.USD","LU2495084118.USD","LU0348766576.USD","LU1719994722.HKD","LU1979443071.USD","LU1997245177.USD","BK1583","IE00BPRC5H50.USD","BK1141","LU2488822045.USD","LU1251922891.USD","LU1997244956.HKD","LU1934453819.USD","LU0708995583.HKD","LU1997245094.SGD","LU1808992512.USD","LU0052750758.USD","LU1046422090.SGD","LU1969619763.USD","LU1770034418.SGD","LU2045819591.USD","LU0456842615.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933421","title":"资金动向|北水加仓MINIMAX超10亿港元,中芯国际遭抛售4.5亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933421","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658933421?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:05","pubTimestamp":1786359956,"startTime":"0","endTime":"0","summary":"跟踪南向资金最新动态","market":"sg","thumbnail":"https://img3.gelonghui.com/35d7c-572a3f6c-6557-4e39-aae0-20705ea0eb8c.jpg?guru_height=852&guru_width=1280&guru_size=135719","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/35d7c-572a3f6c-6557-4e39-aae0-20705ea0eb8c.jpg?guru_height=852&guru_width=1280&guru_size=135719"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5992970","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["00981","01548","KBDCY","LU2929501877.USD","BK1583","LU1328277881.USD","LU0211977185.USD","BK1610","HK0000306701.USD","LU0164880469.USD","LU1282649810.SGD","BK1614","FPA","LU0274383008.USD","HK0000320264.USD","LU2039709279.SGD","BK1506","BK1526","LU0384037296.USD","LU1808992512.USD","LU1282649067.USD","LU2351347302.SGD","BK1141","LU0314109678.HKD","LU0588546209.SGD","688981","00100","BK1607","LU0488056044.USD","BK1170","LU1813983027.USD","MCHS","BK1117","HK0000306685.HKD","LU1282649141.HKD","BK1163","01888","LU1481107354.HKD","00148","LU0648948544.HKD","LU0149721374.USD","LU2187417386.USD","BK1576","LU1211504680.USD","HK0000320223.HKD","SG9999004220.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938739","title":"FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658938739?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:02","pubTimestamp":1786359720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1046422090.SGD","LU0708995583.HKD","LU0320764599.SGD","02359","BK1141","LU2242644610.SGD","LU0348767384.USD","LU0052750758.USD","LU0348766576.USD","LU2045819591.USD","BK1576","LU2125910500.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985600","title":"大行评级|大摩:药明康德获批出初步禁制令 解除1260H清单不明朗因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985600","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985600?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:28","pubTimestamp":1786346889,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0708995583.HKD","IE00BPRC5H50.USD","LU0320764599.SGD","LU1303224171.USD","LU0611395673.USD","LU0456842615.SGD","LU2045819591.USD","LU2125910500.SGD","BK0216","LU1979443071.USD","BK1576","02359","LU1251922891.USD","LU1969619763.USD","BK1141","603259","LU0348766576.USD","LU1997245177.USD","BK1583","LU1808992512.USD","LU0052750758.USD","LU2328871848.SGD","IE00B543WZ88.USD","LU2242644610.SGD","IE00B5MMRT66.SGD","LU0700851271.USD","LU2488822045.USD","LU1719994722.HKD","LU0348767384.USD","LU1770034418.SGD","LU1997244956.HKD","LU1997245094.SGD","LU2495084118.USD","LU1934453819.USD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985992","title":"中泰国际:维持药明康德(02359.HK)“买入”评级 目标价216港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985992?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:04","pubTimestamp":1786345467,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02359","LU0320764599.SGD","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","LU0052750758.USD","BK1141","LU2045819591.USD","LU2242644610.SGD","BK1576","BK1583","LU0348767384.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985310","title":"大摩:药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985310?lang=zh_cn&edition=full","pubTime":"2026-08-10 14:47","pubTimestamp":1786344457,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0348767384.USD","BK1583","BK1576","LU2242644610.SGD","LU2045819591.USD","LU0320764599.SGD","LU0708995583.HKD","02359","LU2125910500.SGD","LU0348766576.USD","LU1046422090.SGD","BK1141","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604503","title":"金斯瑞生物科技盘中涨超8% 全球AI制药落地进入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604503","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658604503?lang=zh_cn&edition=full","pubTime":"2026-08-10 11:26","pubTimestamp":1786332360,"startTime":"0","endTime":"0","summary":"全球AI制药落地进入兑现期。美股Twist中报业绩超预期,AI相关订单同比翻倍增长,全年营收指引上调至4.56-4.57亿美元。据悉,金斯瑞生命科学事业群覆盖DNA合成、蛋白生产、抗体开发及功能验证,可以将AI生成序列进一步转化为实体蛋白及实验数据。AI驱动药物开发及多抗体药物开发需求增长,带动基因至蛋白业务快速成长;2025年生命科学事业群收入5.22亿美元,同比增长14.8%,同时持续扩大自动化、数字化生产能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-10/doc-inimuzxp1267880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01548","BK1141","BK1191","AGIX","CHAT","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD","BK1576","BK1574","ARTY","VTHR","QTOC","AIPO","01477","HK0000320223.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658043626","title":"时隔5个月,华宝基金医疗ETF(512170)重新站上年线!药明康德A股突破上轮医药牛市高点,创上市8年新高!","url":"https://stock-news.laohu8.com/highlight/detail?id=2658043626","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658043626?lang=zh_cn&edition=full","pubTime":"2026-08-10 11:17","pubTimestamp":1786331820,"startTime":"0","endTime":"0","summary":"8月10日,A股医疗板块继续向上!CXO再爆发,博腾股份、康龙化成续涨超5%,权重龙头药明康德A股盘中飙升逾7%,一举突破上轮医药牛市前高,创历史新高!全市场规模最大医疗ETF华宝继上日大涨4.53%后,盘中再度冲上4%,场内价格创本轮反弹新高,时隔5个月重新站上年线,不到半日成交额近10亿元!数据显示,医疗ETF华宝标的指数覆盖8只CXO龙头股,最新权重合计32.82%,其中药明康德占比13.42%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0708995583.HKD","09939","IE00BPRC5H50.USD","IE00B543WZ88.USD","02359","LU2328871848.SGD","LU1979443071.USD","LU0052750758.USD","603259","LU2242644610.SGD","LU0348767384.USD","LU0456842615.SGD","BK1161","LU1251922891.USD","LU2495084118.USD","IE00B5MMRT66.SGD","LU0320764599.SGD","LU1303224171.USD","LU2045819591.USD","LU0611395673.USD","LU1808992512.USD","LU0348766576.USD","LU1997245177.USD","LU2125910500.SGD","BK1141","BK1583","159828","LU2488822045.USD","BK1515","159938","LU1934453819.USD","LU1770034418.SGD","LU0700851271.USD","399300","BK0216","LU1046422090.SGD","LU1997244956.HKD","512170","159982","LU1997245094.SGD","IPOS","BK1576","LU1719994722.HKD","BK1574","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658601687","title":"AH异动丨药明康德H股创新高,A股涨超7%,美法院批准针对1260H认定的初步禁令","url":"https://stock-news.laohu8.com/highlight/detail?id=2658601687","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658601687?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:37","pubTimestamp":1786329454,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1997245094.SGD","LU2045819591.USD","BK1583","LU2328871848.SGD","IE00B5MMRT66.SGD","159982","LU2495084118.USD","LU1934453819.USD","LU0708995583.HKD","LU2488822045.USD","IE00BPRC5H50.USD","BK1141","LU1770034418.SGD","LU1969619763.USD","IE00B543WZ88.USD","LU1251922891.USD","LU2242644610.SGD","LU0348766576.USD","LU1997244956.HKD","LU0052750758.USD","02359","LU0348767384.USD","LU1979443071.USD","LU1719994722.HKD","LU1997245177.USD","LU2125910500.SGD","LU1808992512.USD","399300","LU0456842615.SGD","BK0216","LU1303224171.USD","LU0611395673.USD","603259","LU1046422090.SGD","BK1576","LU0700851271.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658015036","title":"港股异动 | 金斯瑞生物科技(01548)涨超8% AIDD放大实验验证需求 机构看好“卖水人”逻辑强化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658015036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658015036?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:31","pubTimestamp":1786329118,"startTime":"0","endTime":"0","summary":"消息面上,全球AI制药落地进入兑现期。美股Twist中报业绩超预期,AI相关订单同比翻倍增长,全年营收指引上调至4.56-4.57亿美元。据悉,金斯瑞生命科学事业群覆盖DNA合成、蛋白生产、抗体开发及功能验证,可以将AI生成序列进一步转化为实体蛋白及实验数据。AI驱动药物开发及多抗体药物开发需求增长,带动基因至蛋白业务快速成长;2025年生命科学事业群收入5.22亿美元,同比增长14.8%,同时持续扩大自动化、数字化生产能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","HK0000320223.HKD","BK4585","VXUS","BK1576","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD","01548","BK4588","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609113","title":"医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609113","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609113?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:58","pubTimestamp":1786327110,"startTime":"0","endTime":"0","summary":"消息面上,国金证券发布研报指,CXO行业已完整经历一轮产业周期,当下行业景气度上行信号明确。目前,随着外部压力缓释、全球投融资回暖,国内BD持续升温,行业已进入内外需共振、新分子赛道放量、订单与业绩逐季改善的新一轮复苏上行周期。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987777","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0708995583.HKD","LU0823426480.USD","159938","LU0181495838.USD","LU0823426308.USD","BK1141","06127","09939","BK1191","BK1521","LU0140636845.USD","LU0456827905.SGD","02269","01548","HK0000306701.USD","LU1720050803.USD","LU0417516738.SGD","LU2039709279.SGD","LU2125910500.SGD","BK1589","06821","BK1574","LU1046422090.SGD","SG9999002562.SGD","IE00B0JY6N72.USD","KURE","LU1242518857.USD","BK1515","LU0307460666.USD","LU0588546209.SGD","02359","HK0000320264.USD","LU0979878070.USD","LU0052750758.USD","LU0516422366.SGD","01521","LU1880383366.USD","01873","BK1161","LU0819121731.USD","LU2242644610.SGD","LU0320764599.SGD","LU1242518931.SGD","LU0348767384.USD","LU0051755006.USD","LU3063872942.SGD","LU0043850808.USD","LU0572944931.SGD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609667","title":"港股生物医药股盘初走高,药明康德股价突破200港元关口创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609667","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609667?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:51","pubTimestamp":1786326707,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端港股生物医药股盘初走高,药明康德一度涨超5%,股价突破200港元关口创历史新高,现涨超4%;再鼎医药涨超5%,诺诚建华、药明生物涨超3%。开源证券发布研报表示,投资上,我们建议重点关注减重代谢领域中口服司美格鲁肽及Foundayo两个确定性的增量机会。同时,药明康德小分子D&M 业务大体量下加速增长,预示着国内小分子CDMO 板块有望在未来3-5年迎来增长新周期,相关公司的签单收入有望逐步加速,利润端有望超预期增长。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-08-10/doc-inimuvrt8236475.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VXUS","BK4585","IE00B543WZ88.USD","02359","LU2328871848.SGD","BK4581","LU2242644610.SGD","LU0611395673.USD","LU0708995583.HKD","LU1997244956.HKD","LU2495084118.USD","LU0456842615.SGD","LU0320764599.SGD","KCAI","LU1969619763.USD","161726","LU0348767384.USD","LU1303224171.USD","LU1979443071.USD","BK0216","LU1808992512.USD","LU1934453819.USD","EWH","LU1770034418.SGD","XBI","BK4588","LU0348766576.USD","BK1583","IE00BPRC5H50.USD","LU0700851271.USD","LU0052750758.USD","LU2125910500.SGD","LU2488822045.USD","BK1576","LU1251922891.USD","09688","BK1141","09969","LU1719994722.HKD","LU1997245177.USD","LU2045819591.USD","LU1046422090.SGD","IE00B5MMRT66.SGD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0729},{"period":"3month","weight":-0.0156},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0434},{"period":"ytd","weight":0.012}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1576","nameEN":"BK1576"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药外包概念(BK1576)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药外包概念(BK1576)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药外包概念,BK1576,医药外包概念股票,医药外包概念股票老虎,医药外包概念股票老虎国际,医药外包概念行情,医药外包概念股票行情,医药外包概念股价,医药外包概念股市,医药外包概念股票价格,医药外包概念股票交易,医药外包概念股票购买,医药外包概念股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药外包概念(BK1576)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药外包概念(BK1576)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}